Skip to content
XPR – Lifestyle Demo
Author:
Laigo Bio
Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs
March 23, 2026